Diarrhea News and Research

Latest Diarrhea News and Research

Chemicals in curry and onions may help prevent colon cancer

A small but informative clinical trial by Johns Hopkins investigators shows that a pill combining chemicals found in turmeric, a spice used in curries, and onions reduces both the size and number of precancerous lesions in the human intestinal tract.

1 Aug 2006

Interaction of proteins in the intestinal system may be allergic indicators

Researchers have identified one of the proteins that may be responsible for causing food allergies, which could lead to the development of more accurate non-invasive tests to identify true food allergies.

25 Jul 2006

Lassa fever reported in Germany

German health authorities have reported to WHO an imported case of Lassa fever, confirmed by laboratory tests at the Bernhard-Nocht-Institute of Tropical Medicine, Hamburg, Germany.

25 Jul 2006

Antibiotics should not used to treat a runny nose

Antibiotics should not be given to patients with acute purulent rhinitis (a runny nose with coloured discharge), a familiar feature of the common cold, concludes a study published on the British Medical Journal website.

21 Jul 2006

Neuraminidase inhibitors for preventing and treating influenza in healthy adults

A class of drugs commonly used to treat typical influenza symptoms such as fever, headache and cough do not prevent people from becoming infected with the flu virus.

19 Jul 2006

Cleaning water at household is best diarrhea prevention

Clean water can prevent diarrhea and save lives, but among the world's most susceptible populations, it is cleaned best at its point of use rather than its source, researchers report in a large new review of studies.

19 Jul 2006

FDA approves Atripla for the treatment of HIV-1 infection in adults

Bristol-Myers Squibb Company and Gilead Sciences have announced the U.S. Food and Drug Administration (FDA) has granted approval of Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) for the treatment of HIV-1 infection in adults.

13 Jul 2006

Celiac success: New enzyme efficiently degrades gluten

A new enzyme originally developed for commercial food processing turns out to also quickly and nearly-completely break down whole gluten molecules as well as the T cell stimulatory peptides that cause celiac disease, a digestive disease with no current effective treatment other than avoiding wheat, barley or rye products.

5 Jul 2006

Enter hospital at your peril!

As many as two dozen patients at a British hospital have died after contracting the virulent stomach bug Clostridium difficile (C. diff).

3 Jul 2006

FDA grants accelerated approval for Sprycel (dasatinib)

FDA grants accelerated approval for Sprycel (dasatinib), a new oral treatment for patients with chronic myeloid leukemia (CML),

29 Jun 2006

Structure of bacteriophage shown to resemble a human virus

New research has revealed that the structure of a bacteriophage, a virus infecting bacteria, resembles that of certain dangerous viruses that infect people.

26 Jun 2006

FDA approves Prezista (darunavir)

FDA approves Prezista (darunavir), a new drug for adults whose infection with the human immunodeficiency virus (HIV) has not responded to treatment with other antiretroviral drugs.

26 Jun 2006

Cadbury kept quiet about contaminated chocolate

Chocolate manufacturer Cadbury Schweppes has been forced to recall thousands of chocolate bars because of claims they are contaminated by salmonella.

26 Jun 2006

Colonel Sanders goes to court

The fast food chain Kentucky Fried Chicken (KFC) is about to be sued over it's cooking methods.

20 Jun 2006

Microbes could represent the future of medicine

Not all bacteria are bad. In fact, beneficial microbes could represent the future of medicine, with the potential to treat a variety of diseases in humans and animals from diarrhea and eczema to gum disease and autoimmune disorders.

9 Jun 2006

New football boots and toxic shock syndrome

As the World Cup kicks off, doctors in this week's British Medical Journal report an unusual condition that can develop in budding young footballers.

8 Jun 2006

Sunitinib shows promise in treating metastatic renal cell cancer

A new study suggests that sunitinib is a promising agent for treatment of metastatic renal cell cancer, currently a disease without highly effective treatment options, according to an article in the June 7 issue of the Journal of the American Medical Association.

7 Jun 2006

Long-term benefits of imatinib for patients newly diagnosed with chronic myelogenous leukemia

The overall survival of most people with chronic myelogenous leukemia (CML) treated with imatinib (Gleevec, STI-571) is extremely high and the relapse rate is quite low, according to new data from a study out of the Oregon Health & Science University Cancer Institute.

6 Jun 2006